Shreya Patil  oprettet en ny artikel
16 timer

Antisense Oligonucleotide for Genetic and Rare Disorders Market Growth Opportunities and Competitive Outlook | #antisense Oligonucleotide for Genetic and Rare Disorders Market

Antisense Oligonucleotide for Genetic and Rare Disorders Market Growth Opportunities and Competitive Outlook

Antisense Oligonucleotide for Genetic and Rare Disorders Market Growth Opportunities and Competitive Outlook

The global antisense oligonucleotide for genetic and rare disorders market size was valued at USD 529.26 billion in 2024 and is expected to reach USD 1,563.55 billion by 2032, at a CAGR of 14.50% during the forecast period.